Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01281189
Brief Title: Phase 3 Study of Dexpramipexole in ALS (EMPOWER)

First Submitted : January 20, 2011
First Submitted that Met QC Criteria : January 20, 2011
First Posted : January 21, 2011 (Estimate)

Results First Submitted : December 4, 2020
Results First Submitted that Met QC Criteria : May 10, 2021
Results First Posted : June 7, 2021

Certification/Extension First Submitted : November 24, 2014
Certification/Extension First Submitted that Met QC Criteria : November 24, 2014
Certification/Extension First Posted : November 25, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : May 10, 2021
Last Update Posted : June 7, 2021